No press releases found.
Piper Sandler Reaffirms Their Hold Rating on Claritev (CTEV)
TipRanks (Mon, 10-Mar 6:46 AM ET)
Claritev to Release Investor Presentation on March 2025
TipRanks (Wed, 5-Mar 9:29 AM ET)
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Claritev Class A trades on the NYSE stock market under the symbol CTEV.
As of March 10, 2025, CTEV stock price declined to $17.35 with 72,029 million shares trading.
CTEV has a market cap of $281.04 million. This is considered a Small Cap stock.
Last quarter Claritev Class A reported $232 million in Revenue and -$5.16 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$2.83.
The top ETF exchange traded funds that CTEV belongs to (by Net Assets): BSVO, FNDA, SCHA, PRFZ, ITOT.
CTEV support price is $17.08 and resistance is $19.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.